Alaunos Therapeutics, Inc.

TCRTReported to SECin USCIK 0001107421Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 6. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 6
Form 4 lines at Alaunos Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Weis HolgerCEOAward$8,7704,363 sharesAug 11, 2026Weis HolgerCEO$8,770Award · Aug 11Award4,363Aug 11, 2026
Jerman Michael Allen—Award$15,6258,138 sharesJul 27, 2026Jerman Michael Allen$15,625Award · Jul 27Award8,138Jul 27, 2026
Weis HolgerCEOAward$8,7714,568 sharesJul 27, 2026Weis HolgerCEO$8,771Award · Jul 27Award4,568Jul 27, 2026
Postma Robert W—Award$16,2498,463 sharesJul 27, 2026Postma Robert W$16,249Award · Jul 27Award8,463Jul 27, 2026
Vieser Jaime—Award$16,8758,789 sharesJul 27, 2026Vieser Jaime$16,875Award · Jul 27Award8,789Jul 27, 2026